Alba Font‐Tello

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu et al. · Nature Genetics · 2020 · 271 citations · Full text

Developmental Biology, Epigenomics, Cancer Genomics +3

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Shengqing Gu, Wubing Zhang, Xiaoqing Wang et al. · Cancer Discovery · 2021 · 267 citations · Full text

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Shaokun Shu, Hua‐Jun Wu, Jennifer Y. Ge et al. · Molecular Cell · 2020 · 197 citations · Full text

Breast Oncology, Medicine, Resistance Interactions +9

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink et al. · Nature Medicine · 2019 · 179 citations · Full text

Tumor Biology, Pancreatic Cancer, Medicine +6

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

Paloma Cejas, Yingtian Xie, Alba Font‐Tello et al. · Nature Communications · 2021 · 153 citations · Full text